The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index; 2 of the 6 sources its claims cite were checked for support.
How AI is used in FDA-authorized medical devices: a taxonomy across 1,016 authorizations
Open accessPublished version of a preprint
Abstract
We reviewed 1016 FDA authorizations of AI/ML-enabled medical devices to develop a taxonomy capturing key variations in clinical and AI-related features. Quantitative image analysis remains the most common application, but its relative proportion has declined recently. Over 100 devices leverage AI for data generation, though none yet involve LLMs. Our taxonomy clarifies current AI usage in medical devices and provides a foundation for tracking developments as applications evolve.
Overview
CoChat Summary
TL;DR
The authors reviewed all 1,016 FDA authorizations of AI/ML-enabled medical devices listed as of December 20, 2024 and built a taxonomy around clinical function, AI function, and data type. They found that image-based quantitative analysis dominates, but its share has declined recently; more than 100 devices use AI for data generation, and no authorized devices in the list used LLMs.
Key findings
- Across 1,016 FDA authorizations, the authors identified 736 unique devices.
- By data type, 621 devices (84.4%) use images, 107 (14.5%) use signals, 5 (0.7%) use ‘omics data, and 3 (0.4%) use tabular EHR data.
- By clinical function, 84.1% are Assessment devices and 15.9% are Intervention devices; by AI function, 630 devices (85.6%) are Analysis, 83 (11.3%) are Generation, and 23 (3.1%) are both.
- Among Analysis devices, 427 (65% of Analysis devices; 58% of all devices) are quantification/feature localization; among Generation devices, 84 (79.2%) are image enhancement, and 106 devices in total perform Generation.
- Trends over time: image-based devices peaked at 94% of new devices in 2021 and were 81% in 2024 so far; quantification/feature localization peaked at 81% in 2016 and declined to 51% in 2024.
- The authors report no evidence of large language models (LLMs) in the studied device list.
Methods
- The study is a descriptive taxonomy study of the FDA’s published AI/ML-enabled medical device list, accessed from an update on December 20, 2024 and covering authorizations up to September 27, 2024.
- The team reviewed authorization summaries and product codes, then manually assigned each device four taxonomy factors: data type, clinical function, AI function, and AI function subclass.
- They grouped multiple authorizations into unique devices using semi-automated matching by product code, company name, device name, and indication for use, followed by manual review; trend analyses were done at the device level using the earliest authorization for each device.
Limitations
- The paper states that authorization summaries provide only a snapshot, so AI/ML use was sometimes ambiguous; the authors therefore emphasize overall trends rather than precise class counts.
- It states that the summaries often did not reveal the full form or extent of AI/ML involvement, so the taxonomy captures end use rather than the specific AI method or whether the AI function was fully automated versus clinician-adjusted.
- It states the study relied on manual curation because automated LLM-based classification was insufficient; it also notes dependence on the FDA’s published list, which is updated irregularly.
- Evident from the text: because the database is based on the FDA list of authorized devices, it does not include devices used through other regulatory pathways such as investigational device exemption or humanitarian device exemption.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
1 Valid · 1 Not valid · 0 Not checked · 42 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The percentage of authorizations that represent updated versions of existing devices has averaged 34% over 2022–2024, compared to 14% between 2017–2019 (Supplementary Fig. 1).”
§ How AI is used in FDA-authorized medical devices: a taxonomy across 1,016 authorizations > Abstract
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, we did not find evidence of large language models (LLMs) in the studied device list.”
§ How AI is used in FDA-authorized medical devices: a taxonomy across 1,016 authorizations > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Signals include time series such as ECG and EEG, with cardiovascular (64.5%), neurology (16.8%), and anesthesiology (12.1%) representing the most common review panels.”
§ How AI is used in FDA-authorized medical devices: a taxonomy across 1,016 authorizations > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The majority of current devices fall under Assessment (84.1%).”
§ How AI is used in FDA-authorized medical devices: a taxonomy across 1,016 authorizations > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Triage was the next most common Analysis subclass with 84 devices (12.9% of Analysis devices; 11.4% of all devices).”
§ How AI is used in FDA-authorized medical devices: a taxonomy across 1,016 authorizations > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
15 more claims
Create a free account to see all 44 claims and every source verdict.
- It may state two separate claims as one. 19
- Probably not a substantial claim. 7
Citations
Cites
Rajpurkar, P., Chen, E., Banerjee, O., & Topol, E. J. (2022) · Nature Medicine · doi:10.1038/s41591-021-01614-0 · Cited by 3,212
Revolutionizing healthcare: the role of artificial intelligence in clinical practice
Alowais, S. A., Alghamdi, S. S., Alsuhebany, N., Alqahtani, T., Alshaya, A. I., Almohareb, S. N., Aldairem, A., Alrashed, M., Bin Saleh, K., Badreldin, H. A., et al. (2023) · BMC Medical Education · doi:10.1186/s12909-023-04698-z · Cited by 3,146
Deep learning for healthcare applications based on physiological signals: A review
Faust, O., Hagiwara, Y., Hong, T. J., Lih, O. S., & Acharya, U. R. (2018) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2018.04.005 · Cited by 1,026
Wu, E., Wu, K., Daneshjou, R., Ouyang, D., Ho, D. E., & Zou, J. (2021) · Nature Medicine · doi:10.1038/s41591-021-01312-x · Cited by 494 · cited 1×
“Tothisend,recentanalyseshavecalledforimprovedreporting of the clinical validation performed for FDA authorization 9,14,16,18 and a greateruseofprospectivestudiesoverall 15,17 .”
Joshi, G., Jain, A., Araveeti, S. R., Adhikari, S., Garg, H., & Bhandari, M. (2024) · Electronics · doi:10.3390/electronics13030498 · Cited by 294 · cited 2×
“Our analysis provides complementary insights to other recent reviews of FDA-authorized devices that have examined aspects such as predicate networks 12 , marketing 13 , explainability 7 , regulatory pathways 14 , and clinical validation 9,14 – 18 .”
A Scoping Review of Reporting Gaps in FDA-Approved AI Medical Devices
Muralidharan, V., Adewale, B. A., Huang, C. J., Nta, M. T., Ademiju, P. O., Pathmarajah, P., Hang, M. K., Adesanya, O., Abdullateef, R. O., Babatunde, A. O., et al. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01270-x · Cited by 201 · cited 1×
“Tothisend,recentanalyseshavecalledforimprovedreporting of the clinical validation performed for FDA authorization 9,14,16,18 and a greateruseofprospectivestudiesoverall 15,17 .”
Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future Directions
Lotter, W., Hassett, M. J., Schultz, N., Kehl, K. L., Van Allen, E. M., & Cerami, E. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-1199 · Cited by 196
Self-citationMedical image super-resolution for smart healthcare applications: A comprehensive survey
Umirzakova, S., Ahmad, S., Khan, L. U., & Whangbo, T. K. (2023) · Information Fusion · doi:10.1016/j.inffus.2023.102075 · Cited by 183
Artificial Intelligence in U.S. Health Care Delivery
Sahni, N. R., & Carrus, B. (2023) · New England Journal of Medicine · doi:10.1056/nejmra2204673 · Cited by 175
Muehlematter, U. J., Blüthgen, C., & Vokinger, K. N. (2023) · The Lancet Digital Health · doi:10.1016/s2589-7500(23)00126-7 · Cited by 132
Cited by
Ahmed, F., Naz, N. S., Khan, S., Rehman, A. U., Ismael, W. M., & Khan, M. A. (2026) · BMC Medical Imaging · doi:10.1186/s12880-025-02118-w · Cited by 101
“Nevertheless, the examination of different devices showed that very little explicit XAI was used, suggesting that human-centered design is required to meet the so-called right to explanation [127–129].”
Gong, E. J., Bang, C. S., Lee, J. J., & Baik, G. H. (2025) · Journal of Medical Internet Research · doi:10.2196/84120 · Cited by 94
“Moreover, analysis of 1016 Food and Drug Administration (FDA)–authorized AI or machine learning medical devices revealed that no devices using LLMs have received regulatory clearance as of 2024 [5].”
Assudani, P. J., Bhurgy, A. S., Kollem, S., Bhurgy, B. S., Ahmad, M. O., Kulkarni, M. B., & Bhaiyya, M. L. (2025) · Microchemical Journal · doi:10.1016/j.microc.2025.115802 · Cited by 43
Shujaat, S., Aljadaan, H., Alrashid, H., Aboalela, A. A., & Riaz, M. (2025) · International Dental Journal · doi:10.1016/j.identj.2025.109315 · Cited by 21
“As a result, these broad product codes may not fully describe the multifunctional capabilities of modern AI platforms, 183 making it more difficult for clinicians and regulators to assess and compare products based solely on these classifications.”
Kumar, G., Virmani, T., Sharma, A., Goel, B., Chitranshi, N., Akhtar, M. S., Orayj, K., Duarte, J. G., & Mascarenhas‐Melo, F. (2026) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2026.125005 · Cited by 15
Metadata
- Authors
- Singh, R., Bapna, M., Diab, A. R., Ruiz, E. S., & Lotter, W.
- Affiliations
- Dana-Farber Cancer Institute (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Lotter, William
- Venue
- npj Digital Medicine
- Published
- 2025-07-01
- Volume
- 8
- Issue
- 1
- Pages
- 388-388
- ISSN
- 2398-6352 (ISSN-L)
- PMC
- PMC12219150
- OpenAlex
- W4411886794
- Cited by
- 61
- References
- 19
- Citations by year
- 2026: 53 · 2025: 8
- FWCI
- 14.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- npj Digital Medicine (publishedVersion, cc-by-nc-nd)
- medRxiv (acceptedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ellison Foundation
- Wong Family Award
- National Institute of Biomedical Imaging and Bioengineering (R21EB035247)
- Topics
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Healthcare Regulation
- Physical Sciences › Computer Science › Information Systems › Internet of Things and AI
- Keywords
- AI-enabled medical devices, machine learning, artificial intelligence in healthcare, quantitative image analysis, synthetic data generation, large language models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: How AI is used in FDA-authorized medical devices: a taxonomy across 1,016 authorizations. https://app.cochat.ai/papers/10.1038/s41746-025-01800-1
- The paper
- Singh, R., Bapna, M., Diab, A. R., Ruiz, E. S., & Lotter, W. (2025). How AI is used in FDA-authorized medical devices: a taxonomy across 1,016 authorizations. npj Digital Medicine. https://doi.org/10.1038/s41746-025-01800-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.